Survival of European women with gynaecological tumours, during the period 1978-1989

G. Gatta, M. B. Lasota, A. Verdecchia

Research output: Contribution to journalArticle

Abstract

This study concerns the survival of European patients diagnosed between 1978 and 1989 with cancer of corpus and cervix uteri and ovary. Variations in survival in relation to age, country and period of diagnosis were examined. Data from the EUROCARE study were supplied by population-based cancer registries in 17 countries to a common protocol. Five years after diagnosis, relative survival rates were 75, 62 and 35% for cancers of the endometrium, cervix and ovary, respectively. Survival decreased markedly with age. The decrease was especially evident for ovarian cancer, which declined from 65% (15-45 years) to 18% (75+ years). In 1985-1989 there were important inter- country differences in survival for European women with gynaecological cancers: Eastern European countries were characterised by low 5-year relative survival whilst in Sweden, Austria, The Netherlands and Switzerland survival was generally higher than for other European countries. From 1978-1989, 5- year relative survival improved slightly for cervical cancer and improved more among the oldest patients. Prognosis also improved slightly for patients with ovarian tumours and this increase (around 20%) was concentrated among patients between 15 and 64 years of age. Intercountry differences in survival did not in general reduce over time, although for ovarian cancer survival differences narrowed probably in relation to the more widespread use of more effective chemotherapy. Intercountry and time differences in survival for cervical cancer are almost certainly related to variations in the effectiveness of cervical screening programmes. For corpus uteri cancer there was no improvement in survival over the period of this study and intercountry survival differences for this cancer are probably related to differences in patient management.

Original languageEnglish
Pages (from-to)2218-2225
Number of pages8
JournalEuropean Journal of Cancer
Volume34
Issue number14
DOIs
Publication statusPublished - Dec 1998

Fingerprint

Survival
Neoplasms
Uterine Cervical Neoplasms
Ovarian Neoplasms
Uterine Neoplasms
Austria
Endometrial Neoplasms
Switzerland
Sweden
Cervix Uteri
Netherlands
Registries
Ovary
Survival Rate
Drug Therapy
Population

Keywords

  • Age contrasts
  • Cervix cancer
  • Endometrium cancer
  • Europe
  • Ovarian cancers
  • Population-based cancer registries
  • Relative survival
  • Survival trends

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Survival of European women with gynaecological tumours, during the period 1978-1989. / Gatta, G.; Lasota, M. B.; Verdecchia, A.

In: European Journal of Cancer, Vol. 34, No. 14, 12.1998, p. 2218-2225.

Research output: Contribution to journalArticle

Gatta, G. ; Lasota, M. B. ; Verdecchia, A. / Survival of European women with gynaecological tumours, during the period 1978-1989. In: European Journal of Cancer. 1998 ; Vol. 34, No. 14. pp. 2218-2225.
@article{28cc853641f7414c9ce3c3126e85a2f3,
title = "Survival of European women with gynaecological tumours, during the period 1978-1989",
abstract = "This study concerns the survival of European patients diagnosed between 1978 and 1989 with cancer of corpus and cervix uteri and ovary. Variations in survival in relation to age, country and period of diagnosis were examined. Data from the EUROCARE study were supplied by population-based cancer registries in 17 countries to a common protocol. Five years after diagnosis, relative survival rates were 75, 62 and 35{\%} for cancers of the endometrium, cervix and ovary, respectively. Survival decreased markedly with age. The decrease was especially evident for ovarian cancer, which declined from 65{\%} (15-45 years) to 18{\%} (75+ years). In 1985-1989 there were important inter- country differences in survival for European women with gynaecological cancers: Eastern European countries were characterised by low 5-year relative survival whilst in Sweden, Austria, The Netherlands and Switzerland survival was generally higher than for other European countries. From 1978-1989, 5- year relative survival improved slightly for cervical cancer and improved more among the oldest patients. Prognosis also improved slightly for patients with ovarian tumours and this increase (around 20{\%}) was concentrated among patients between 15 and 64 years of age. Intercountry differences in survival did not in general reduce over time, although for ovarian cancer survival differences narrowed probably in relation to the more widespread use of more effective chemotherapy. Intercountry and time differences in survival for cervical cancer are almost certainly related to variations in the effectiveness of cervical screening programmes. For corpus uteri cancer there was no improvement in survival over the period of this study and intercountry survival differences for this cancer are probably related to differences in patient management.",
keywords = "Age contrasts, Cervix cancer, Endometrium cancer, Europe, Ovarian cancers, Population-based cancer registries, Relative survival, Survival trends",
author = "G. Gatta and Lasota, {M. B.} and A. Verdecchia",
year = "1998",
month = "12",
doi = "10.1016/S0959-8049(98)00326-8",
language = "English",
volume = "34",
pages = "2218--2225",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Ltd",
number = "14",

}

TY - JOUR

T1 - Survival of European women with gynaecological tumours, during the period 1978-1989

AU - Gatta, G.

AU - Lasota, M. B.

AU - Verdecchia, A.

PY - 1998/12

Y1 - 1998/12

N2 - This study concerns the survival of European patients diagnosed between 1978 and 1989 with cancer of corpus and cervix uteri and ovary. Variations in survival in relation to age, country and period of diagnosis were examined. Data from the EUROCARE study were supplied by population-based cancer registries in 17 countries to a common protocol. Five years after diagnosis, relative survival rates were 75, 62 and 35% for cancers of the endometrium, cervix and ovary, respectively. Survival decreased markedly with age. The decrease was especially evident for ovarian cancer, which declined from 65% (15-45 years) to 18% (75+ years). In 1985-1989 there were important inter- country differences in survival for European women with gynaecological cancers: Eastern European countries were characterised by low 5-year relative survival whilst in Sweden, Austria, The Netherlands and Switzerland survival was generally higher than for other European countries. From 1978-1989, 5- year relative survival improved slightly for cervical cancer and improved more among the oldest patients. Prognosis also improved slightly for patients with ovarian tumours and this increase (around 20%) was concentrated among patients between 15 and 64 years of age. Intercountry differences in survival did not in general reduce over time, although for ovarian cancer survival differences narrowed probably in relation to the more widespread use of more effective chemotherapy. Intercountry and time differences in survival for cervical cancer are almost certainly related to variations in the effectiveness of cervical screening programmes. For corpus uteri cancer there was no improvement in survival over the period of this study and intercountry survival differences for this cancer are probably related to differences in patient management.

AB - This study concerns the survival of European patients diagnosed between 1978 and 1989 with cancer of corpus and cervix uteri and ovary. Variations in survival in relation to age, country and period of diagnosis were examined. Data from the EUROCARE study were supplied by population-based cancer registries in 17 countries to a common protocol. Five years after diagnosis, relative survival rates were 75, 62 and 35% for cancers of the endometrium, cervix and ovary, respectively. Survival decreased markedly with age. The decrease was especially evident for ovarian cancer, which declined from 65% (15-45 years) to 18% (75+ years). In 1985-1989 there were important inter- country differences in survival for European women with gynaecological cancers: Eastern European countries were characterised by low 5-year relative survival whilst in Sweden, Austria, The Netherlands and Switzerland survival was generally higher than for other European countries. From 1978-1989, 5- year relative survival improved slightly for cervical cancer and improved more among the oldest patients. Prognosis also improved slightly for patients with ovarian tumours and this increase (around 20%) was concentrated among patients between 15 and 64 years of age. Intercountry differences in survival did not in general reduce over time, although for ovarian cancer survival differences narrowed probably in relation to the more widespread use of more effective chemotherapy. Intercountry and time differences in survival for cervical cancer are almost certainly related to variations in the effectiveness of cervical screening programmes. For corpus uteri cancer there was no improvement in survival over the period of this study and intercountry survival differences for this cancer are probably related to differences in patient management.

KW - Age contrasts

KW - Cervix cancer

KW - Endometrium cancer

KW - Europe

KW - Ovarian cancers

KW - Population-based cancer registries

KW - Relative survival

KW - Survival trends

UR - http://www.scopus.com/inward/record.url?scp=0032427393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032427393&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(98)00326-8

DO - 10.1016/S0959-8049(98)00326-8

M3 - Article

C2 - 10070290

AN - SCOPUS:0032427393

VL - 34

SP - 2218

EP - 2225

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 14

ER -